-
.
.
.corinna already had one child with a genetic disorder that left him unable to sweat or grow teeth normally.
.
- eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
OFF DEAL
218 Used Today